A Study of GB491 in Combination With Letrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer
Clinical trial NCT05851014 · RECRUITING
Trial details
- NCT number
- NCT05851014
- Sponsor
- Genor Biopharma Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-14
- Primary completion
- 2026-01-30
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.